Literature DB >> 12515085

Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy.

Robert F See1, Narsing A Rao.   

Abstract

Advancements in antiretroviral therapy have changed the way we view and treat cytomegalovirus retinitis (CMVR). At one time the diagnosis of CMVR necessitated that most patients undergo daily intravenous infusions of anti-CMV agents. Today, after the restoration of their immune systems, they are able to stop maintenance anti-CMV therapy. HAART failure, resistant strains of CMV, and immune recovery uveitis are growing challenges.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12515085     DOI： 10.1016/s0896-1549(02)00048-2

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN： 0896-1549


  4 in total

1.  Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation.

Authors:  Michiko Kandori; Dai Miyazaki; Keiko Yakura; Naoki Komatsu; Chizu Touge; Ryoko Ishikura; Yoshitsugu Inoue
Journal:  Jpn J Ophthalmol       Date:  2013-08-09       Impact factor: 2.447

2.  Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.

Authors:  I de Schryver; F Rozenberg; N Cassoux; S Michelson; P Kestelyn; P Lehoang; J L Davis; B Bodaghi
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

3.  The human eye (retina): a site of persistent HCMV infection?

Authors:  Jens-Uwe Vogel; Corinna Fleckenstein; Mathias Wagner; Hermann O C Gümbel; Dirk Theegarten; Jindrich Cinatl; Hans Wilhelm Doerr
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-26       Impact factor: 3.117

4.  Cytomegalovirus retinitis in HIV/AIDS patients.

Authors:  C Chiotan; L Radu; R Serban; C Cornăcel; M Cioboata; A Anghel
Journal:  J Med Life       Date:  2014-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.